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Catechol-O-methyltransferase mRNA in the kidney and its appearance
during ontogeny. Catechol-O-methyltransferase (COMT), primarily
present as a soluble cytosolic form (S-COMT), inactivates catechols.
The recent cloning of the rat and human S-COMT from placenta has
allowed us to synthesize complementary oligonucleotide probes to
study the localization of COMT mRNA during development in the rat
kidney and in the adult human kidney using in situ hybridization
histochemistry. In the adult rat kidney, COMT mRNA was detected in
segment S3 of proximal tubule cells in the outer stripe of the outer
medulla, and thick ascending limb of loop of Henle (TAL) in the inner
stripe. COMT mRNA was detected in the prenatal rat kidney as early as
on day 18. In the human kidney, strong hybridization signal was seen in
the medulla and in tubule segments of the cortex. In the adult rat
kidney, COMT mRNA was in addition demonstrated in the transitional
epithelium of the ureter. The results suggest synthesis of COMT and
inactivation of catechols along the distal parts of proximal tubules, in
TAL cells, and in the epithelium of the ureter.
The enzyme catechol-O-methyltransferase (COMT; E.C.
2.1.1.6.) catalyzes the transfer of a methyl group from S-ade-
nosyl-L-methionine to the m-hydroxy group of various cate-
chols [1—3]. The O-methylation reaction is important in the
enzymatic inactivation of catecholamines released from cate-
cholaminergic neurons [4, 5] or circulating in plasma [6, 7]3
enzymatic inactivation of 2-hydroxy-estrogens [8], or the de-
toxification of xenobiotic catechols [9]. At least two isoforms of
COMT exist, of which a soluble form (S-COMT) predominates,
while there are smaller amounts of membrane-bound enzyme
(MB-COMT) [10, 11], the latter having a higher affinity for its
catechol substrates [12, 13].
COMT activity is widely distributed in various tissues includ-
ing, for example, brain [14, 15], liver [16], placenta [17], gut
[18], heart [19], uterus [20] and kidney [14, 21]. In the kidney,
COMT has been demonstrated by immunohistochemistry in the
luminal surface of proximal and distal convoluted tubules and in
collecting ducts [14],
Catecholamines play an important role for the regulation of
renal function, particularly for the regulation of renal sodium
excretion. All catecholamines are freely filtered and the kidney
is responsible fOr at least 15% of the overall plasma clearance of
catecholamines [see 22]. Dopamine is synthesized in proximal
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tubule cells and the concentration of dopamine in renal tissue is
much higher than the concentration of dopamine in the blood.
Catecholamines, filtered, or synthesized in the kidney, will be
excreted in the urine either in native form or as metabolites.
Since catecholamine receptors have been identified in the apical
membrane of renal tubule cells [23], native catecholamines in
the tubular fluid may regulate the function of tubular cells.
Thus, it is important to localize the catecholamine-metabolizing
enzymes in the kidney.
Recently, the cDNAs for rat and human S-COMT [24, 25] and
human MB-COMT [26] have been cloned and characterized. In
this study oligonucleotide probes complementary to rat and
human S-COMT mRNA were synthesized and used for in situ
hybridization histochemistry on sections from rat and human
kidney. The presence and distribution of COMT mRNA was
examined in the kidney during pre- and postnatal development.
Methods
In situ hybridization
Kidneys from Sprague-Dawley rats at prenatal days 18 and
21, within 24 hours of birth, postnatal days 8, 10, 20 and 40,
were dissected out, frozen on dry ice, sectioned at 14 itm in a
cryostat (Dittes, Heidelberg, Germany), and thaw-mounted
onto precleaned ProbeOnTM microscope slides (Fisher Scien-
tific, Pittsburgh, Pennsylvania, USA). A human kidney was
obtained from a nephrectomized patient due to a hyper-
nephroma tumor. Two 48-mer oligonucleotide probes were
synthesized complementary to nucleotides 87-130 of rat [24]
and nucleotides 467-504 of human [25] COMT mRNA. The
probes were 3'-end labeled with 55S-dATP (NEN, Boston,
Massachusetts, USA) using terminal deoxynucleotidyl trans-
ferase (Amersham Ltd., Amersham, UK) and purified using
Nensorb 20 columns (NEN). In situ hybridization was per-
formed essentially as described [27, 281. In brief, the tissue
sections were air-dried and incubated for 16 hours at 42°C with
106 cpm of the labeled probe in a hybridization solution con-
taining 50% deionized formamide (Baker Chemicals, Deventer,
The Netherlands), SSC in 4 >< SSC concentration (1 X SSC =
0.15 M NaCI, 0.015 M sodium-citrate), 1 x Denhardt's solution
[0.02% bovine serum albumin, 0.02% Ficoll (Pharmacia, Upp-
sala, Sweden), 0.02% polyvinylpyrolidone], 1% sarcosyl, 0.02
M NaPO4 (pH 7.0), 10% dextran sulphate (pH 7.0) (Pharmacia),
500 mg/ml denaturated salmon sperm DNA (Sigma, St. Louis,
Missouri, USA) and 200 mrvs dithiothreitol (LKB, Stockholm,
Sweden). After hybridization (16 hours), the sections were
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Fig. 1. Northern blot analysis of total RNA extracted from whole adult
rat kidney after hybridization with an oligonucleotide probe to rat
COMT mRNA. A single transcript of approximately 1.8 kb in length is
observed. The positions of the 28S and 18S ribosomal bands are
indicated.
Fig. 2. Film autoradiograms of sections of rat kidney at postnatal days
40, 20, 10 and 8, within 24 hours of birth, and prenatal days 18 and 21
after in situ hybridization with an oligonucleotide probe to COMT
mRNA. In the adult kidney, strong hybridization signal is distributed in
the outer stripe (Os) of the outer medulla, with rays radiating into the
cortex (c). Weaker labeling is present in the inner stripe (is) of the outer
medulla and also in the papilla (p). Virtually no labeling is present in the
outer cortex or in the inner medulla (im). Note intense labeling in the
ureter (Ut; arrow) in 40 and 20 day old kidneys. COMT mRNA is
apparent in the kidney as early as on prenatal day 18. The strong
labeling in the os is apparent from postnatal day 8. During prenatal day
18 to 10 days postnatally, the COMT mRNA labeling is diffusely
distributed in the cortex. At 20 days there is a more organized pattern
of labeling, with a pattern resembling that seen at 40 days. Bar = 1 mm.
rinsed in 1 x SSC at 55°C for 15 minutes with four changes of ethanol (two minutes each) and apposed to Hyperfilm /3-max
SSC and for 60 minutes at room temperature, transferred autoradiography film (Amersham) at —20°C. After 14 days of
through distilled water, dehydrated through 60% and 95% exposure, the film was developed with Kodak LX 24 for four
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Fig. 3. Film autoradiogram (d), dark- (a,e) and bright-field (b,cJ',g) photomicrographs of emulsion-dipped sections of adult rat (a-c) and human
(d-f) kidneys after in situ hybridization with oligonucleotide probes to COMT mRNA. In rat kidney, labeling is observed in the outer stripe (OS)
and in rays radiating into the cortex (C), and in nephron segments in the inner stripe (IS). In the human kidney, labeling is seen in scattered tubular
structures in the entire cortex (C) and in the medulla (M) (Fig. 3d). After counter-staining with hematoxylin-eosin, it can be seen that silver grains
are overlying proximal tubule cells located in the OS in rat (b; higher magnification in c), and in TAL cells in the M of human (e; higher
magnification in 1) kidney. Bar in a-c 50 m, e and f = 100 m, and in d = 1 mm. (Continued on next page)
minutes and fixed for 15 minutes with Kodak AL 4. Some
sections were dipped in Kodak NTB2 emulsion, exposed for
five weeks at 20°C, and developed in Kodak D19 (4 mm) and
fixed in Kodak 3000 (10 mm). The slides were rinsed in distilled
water and coverslipped with glycerol. In addition, some of
these sections were counter-stained with hematoxylin-eosin,
dehydrated in graded series of ethanol and coverslipped with
Entellan® (Merck, Darmstadt, Germany). All sections were
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examined in a Nikon Microphot-FX microscope equipped for
bright-field and dark-field microscopy. Photographs were taken
with Kodak Tmax 100 ASA black and white film.
Northern analysis
Total RNA from rat kidney was prepared, separated on
agarose gels, and blotted onto Hybond N membranes as previ-
ously described for brain tissue [29]. Membranes were prehy-
bndized in 50% formamide, 5 x SSPE, 0.1% SDS, 2 x
Denhardt's, 100 g/ml denatured salmon sperm DNA, and 200
sg/ml tRNA at 42°C for six hours after which 8 nglml of
32P-labeled oligonucleotide probe were added and incubation
was continued for an additional 18 to 20 hours. Membranes
were washed with 2 x SSPE and 0.1% SDS (2 x 10 mm at
42°C), lx SSPEandO.1%SDS(l x 20minat42°C),and0.l x
SSPE and 0.1% SDS (1 x 10 mm at room temperature) and
apposed to film (Kodak X-Omat).
Results
The Northern blot analysis of total RNA extracted from
whole adult rat kidneys and hybridized with either oligonucle-
otide probe showed a single transcript approximately 1.8 kb in
length (Fig. 1). Using in situ hybridization, both oligonucleotide
probes gave identical labeling patterns with equal intensity in
both rat and human kidney. In film autoradiograms of adult (40
day old) rat kidney, strong COMT labeling was observed in the
outer stripe of the outer medulla, with tubular rays radiating
into the outer part of the cortex (Fig. 2). Weaker labeling was
seen in the inner stripe (Fig. 2). With the exception of very
weak labeling in the papilla, the inner medulla was devoid of
labeling (Fig. 2). In emulsion-dipped and hematoxylin-counter-
stained sections, the labeling was demonstrated in segment S3
of proximal tubules, and in the medullary thick ascending limb
(TAL) of loop of Henle (Fig. 3a-c). The different tubule seg-
ments were identified based on different staining properties with
hematoxylin-eosin (proximal tubules more red that TAL cells)
and morphological appearance (proximal tubules had higher
epithelium and larger lumen as compared to TAL cells). During
development, COMT mRNA was detected diffusely in the
cortex as early as on prenatal day 18 (Fig. 2). At days 18 and 21,
condensations of silver grains were present in the cortex (Fig.
4a,b). During day 18, and until eight days postnatally, the
labeling was diffusely distributed in the cortex and medulla (Fig.
2); however, from 10 days the labeling was distributed in a more
organized pattern, with the strongest labeling in the outer stripe
and tubular rays radiating to the outer cortex (Fig. 2). At 20
days, the labeling in the inner stripe was apparent (Fig. 2). In
emulsion-dipped sections, it was seen that the labeled tubular
rays in the cortex were localized to the inner parts of the cortex
at 24 hours within birth, and were developing towards the outer
cortex at 10 days, to fully reach the outer surface of the cortex
at 20 days (Fig. 4c-e). In the human kidney, COMT mRNA was
seen in small tubular rays scattered in the entire cortex and in
more densely organized in tubules of the medulla (Fig. 3d),
where it in the latter could be identified in TAL cells (Fig. 3e-g).
Intense COMT mRNA labeling was demonstrated in the rat
ureter (Figs. 2 and 5), which in emulsion-dipped and counter-
stained sections was shown to be present in the transitional
epithelium (Fig. 5a-d).
Discussion
The present study shows a nephron-specific distribution of
COMT mRNA in renal tubule cells and shows for the first time
that COMT also is produced in the ureter. In an earlier
immunohistochemical study, COMT-like immunoreactivity was
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Fig. 5. Dark- (a,b) and bright-field (c,d) photomicro graphs of sections of rat ureter after in situ hybridization with an oligonucleotide probe to
COMT mRNA. Strong hybridization signal is demonstrated in the epithelium (ep) of the ureter (see higher magnifications in b and d as indicated
by rectangles in a and c). Bars = 100 m.
demonstrated along the luminal surfaces of the proximal and
distal convoluted tubules and in collecting ducts [141, whereas
in this study COMT mRNA was demonstrated in the straight
portions of proximal and distal tubules and not in collecting
ducts. The reason for the discrepancy between the immunohis-
tochemical and in situ hybridization results is unclear, but
potential cross reactivity of COMT antisera with other antigens
may be considered. In our study specificity was evaluated by
the use of two different oligonucleotide probes complementary
to different parts of COMT mRNA, having similar guanosine/
cytosine content and length, and the same specific activity. The
probes gave identical results with equal intensity in labeling.
Furthermore, the Northern blot analysis showed a transcript of
1.8 kb in length, in agreement with other results [24, 25].
The kidney is the main source of dopamine and dopamine
metaulites in the urine [see 221. Dopamine is produced in the
kidney by conversion of L-DOPA via the enzyme aromatic
L-amino acid decarboxylase (AADC) present in the cytoplasm
of proximal tubule cells [30—35]. The catabolism of dopamine
involves conversion of dopamine into DOPAC via the enzyme
monoamine oxidase (MAO), and/or conversion of dopamine
into 3-methoxytyramine (MTA) via COMT. DOPAC and MTA
can be further converted into homovanillic acid by COMT and
MAO, respectively. Homovanillic acid (HVA) is by far the
major metabolite of dopamine excreted by the urine [see 36].
Only small fractions of dopamine metabolites seem to be
excreted as a conjugate, and the small amounts of free urinary
dopamine appears to be derived mainly from the decarboxyla-
tion of circulating DOPA [37]. The metabolism of norepineph-
rifle also involves both MAO and COMT, and the main urinary
Fig. 4. Dark-field photomicrographs of sections of rat kidney at prenatal day 18(a) and 21(b), within 24 hours of birth (c), and at postnatal day
10(d) and 20 (e) after in situ hybridization with an oligonucleotide probe to COMT mRNA. At day 18, weak labeling is observed in the cortex, with
some condensations showing more intense labeling (arrows in a). At day 21, more condensations of labeled cells are present throughout the cortex
(b). Within 24 hours of birth, labeling is shown in the inner cortex with particularly strongly labeled tubule cells radiating towards the outer part
of the cortex (c). At 10 days postnatally, several of the intensely labeled tubule cells are reaching the surface of the outer cortex (d), and at 20 days
many tubule cells are distributed in the outer cortex, reaching the renal capsule (e). Bars = 50 m.
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excretion product of norepinephrine is vanillyl mandelic acid
(VMA). The demonstration of COMT synthesis in the kidney,
coupled with studies on the effect of the COMT-inhibitor
nitecapone on L-DOPA metabolism in healthy volunteers,
indicates that COMT is of importance for renal dopamine
metabolism [38]. Thus, when nitecapone was given concomi-
tantly with L-DOPAlcarbidopa, it decreased the urinary excre-
tion of MTA and HVA [381,
Previous studies dealing with the inactivation and metabolism
of catecholamines in the kidney have focused on MAO [39, 40].
In rat kidney slices loaded with L-DOPA, inhibition of MAO-A
increased the accumulation of newly formed dopamine and
reduced DOPAC formation, whereas inhibition of MAO-B did
not affect dopamine formation, but decreased DOPAC levels
[39, 401. These results suggest that most of the MAO that is
located inside tubular cells, in which dopamine synthesis takes
place, is of the A-type [41]. In contrast, MAO-B, which is the
dominating type in the cat renal cortex [42], may be located
outside the compartment where dopamine synthesis occurs and
would be responsible for the deamination of dopamine which
leaks from renal tubule cells.
Selective presence of COMT mRNA in the S3 segment of
proximal tubules and in TAL cells is interesting. Dopamine is
produced in the Si and S2 segments of proximal tubules [22].
The highest levels of excreted dopamine would consequently be
expected to be encountered along the distal parts of proximal
tubules, where inactivation of excessive dopamine should oc-
cur. In our study, the highest expression of COMT mRNA was
demonstrated in the S3 segment of proximal tubules, whereas
the expression in the TAL cells was lower, in agreement with
this hypothesis.
Catecholamines play an important role for the regulation of
renal sodium excretion [35]. It is possible that the level by
which COMT is expressed in the kidney contributes to the
modulation of renal sodium homeostasis. In fact, COMT
mRNA levels appear to undergo dynamic changes after exper-
imental manipulations. In this regard, we have recently shown
that administration of 2% saline as drinking water results in
changes in the COMT mRNA levels in the kidney (Meister et al,
unpublished results).
The observation that COMT mRNA is present in the ureter
suggests that the COMT produced is involved in inactivation of
circulating catecholamines, rather than catecholamines re-
leased from noradrenergic nerve fibers in the smooth muscle
layers of the ureter. Occurrence of COMT mRNA in the
transitional epithelium suggests catabolism of urinary cate-
cholamines even at a site located more distally to the nephron,
and may serve to inactivate the excess of catecholamines that is
not metabolized by renal tubule cells.
COMT mRNA was observed in the kidney of fetal and
newborn rats. In these kidneys, COMT mRNA was diffusely
located in the cortex. In the fetal kidneys, COMT mRNA was
particularly well-expressed in the undifferentiated mesenchy-
mal cells, which may suggest that catecholamines play a role for
the formation of nephrons. Future studies are necessary to
determine the role of COMT in the fetal kidney and factors of
importance for the regulation of COMT mRNA in the mature
kidney,
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